Neuroblastoma Therapy
Researchers' work from G. Gaslini Children's Hospital focuses on neuroblastoma therapy
Published in Hospital Business Week, December 14th, 2008
Data detailed in 'Enhanced antitumor efficacy of clinical-grade vasculature-targeted liposomal doxorubicin' have been presented. According to recent research from Genoa, Italy, "In vivo evaluation of good manufacturing practice-grade targeted liposomal doxorubicin (TVT-DOX), bound to a CD13 isoform expressed on the vasculature of solid tumors, in human tumor xenografts of neuroblastoma, ovarian cancer, and lung cancer. Mice were implanted with lung, ovarian, or neuroblastoma tumor cells via the pulmonary, peritoneal, or orthotopic (adrenal gland) routes, respectively, and treated, at different days post inoculation, with multiple doses of doxorubicin, administered either free or...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital Business Week
More Articles from Hospital Business Week
- A.M. Best Company
A.M. Best Downgrades Ratings of Health Net, Inc. and Its Subsidiaries - Abdominal Aortic Aneurysm
Medtronic Launches New Medical Device In U.S. To Improve Treatment of Aortic Aneurysms - Achalasia
Scientists at Woodville SA target achalasia - Advanced Sterilization Products
ASP Announces Availability of CLEANASCOPE System - Agency for Healthcare Research & Quality
Final Rule Issued for Patient Safety Organizations - Album Creative Studios, Inc.
Album Creative Studios Tailors Big Brand Marketing for Small Businesses - More from this issue of Hospital Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
